Favipiravir Tablet to be Available in 400mg for COVID-19 Treatment

BDR Pharmaceuticals has planned to launch 400mg Favipiravir tablets after approval from DCGI. It will cost Rs 990 for a strip of 10 'Favipiravir 400 mg' tablets. The Favipiravir tablets are currently available in 200 mg and are being used to treat COVID-19 patients with 'mild-symptoms'. "Introducing a higher dosage is an attempt to ensure a smoother experience to patients and caregivers," BDR Pharma CMD Dharmesh Shah said.